Related Experiment Video
Updated: May 15, 2026

Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
Published on: December 2, 2015
Degree of fetal growth restriction associated with schizophrenia risk in a national cohort
M G Eide1, D Moster, L M Irgens
1Norwegian Institute of Public Health, Bergen, Norway. martha.eide@mfr.uib.no
Insights
Fetal growth restriction, measured by birth weight and length z scores, is linearly associated with increased schizophrenia risk. Maternal pre-eclampsia also elevates schizophrenia risk, suggesting a role for fetal development in the disorder.
Area of Science:
- Perinatal epidemiology
- Psychiatric genetics
- Developmental neuroscience
Background:
- Fetal growth restriction is a potential risk factor for schizophrenia.
- Previous studies have not directly examined the dose-response relationship between fetal growth restriction and schizophrenia risk.
- Maternal pre-eclampsia, linked to placental dysfunction and poor fetal growth, is also investigated for its association with schizophrenia.
Purpose of the Study:
- To investigate the linear relationship between the degree of fetal growth restriction and the risk of developing schizophrenia.
- To determine if maternal pre-eclampsia is associated with an increased risk of schizophrenia.
Main Methods:
- A population-based cohort study of 873,612 single live births in Norway (1967-1982) was followed to adulthood.
- Schizophrenia diagnosis (n=2207) was ascertained through the National Insurance Scheme.
- Fetal growth restriction was quantified using sex-specific z scores for birth weight and birth length for gestational age; maternal pre-eclampsia was recorded based on defined criteria.
Main Results:
- Schizophrenia risk showed a linear increase with decreasing birth weight for gestational age z scores (p-trend=0.005).
- The adjusted odds ratio for schizophrenia in the lowest birth weight z-score category (< -3.00) was 2.0 (95% CI 1.2–3.5).
- Similar trends were observed for birth length z scores, and maternal pre-eclampsia was associated with a 1.3-fold increased risk of schizophrenia (95% CI 1.0–1.8).
Conclusions:
- The degree of fetal growth restriction and maternal pre-eclampsia are associated with schizophrenia risk.
- These findings highlight the importance of studying mechanisms influencing fetal growth, including placental function, in the etiology of schizophrenia.
Background:
Accumulating evidence suggests that fetal growth restriction may increase risk of later schizophrenia but this issue has not been addressed directly in previous studies. We examined whether the degree of fetal growth restriction was linearly related to risk of schizophrenia, and also whether maternal pre-eclampsia, associated with both placental dysfunction and poor fetal growth, was related to risk of schizophrenia.
Method:
A population-based cohort of single live births in the Medical Birth Registry of Norway (MBRN) between 1967 and 1982 was followed to adulthood (n=873 612). The outcome was schizophrenia (n=2207) registered in the National Insurance Scheme (NIS). The degree of growth restriction was assessed by computing sex-specific z scores (standard deviation units) of ‘ birth weight for gestational age’ and ‘ birth length for gestational age’. Analyses were adjusted for potential confounders. Maternal pre-eclampsia was recorded in the Medical Birth Registry by midwives or obstetricians using strictly defined criteria.
Results:
The odds ratio (OR) for schizophrenia increased linearly with decreasing birth weight for gestational age z scores (p value for trend=0.005). Compared with the reference group (z scores 0.01–1.00), the adjusted OR [95% confidence interval (CI)] for the lowest z-score category (
Conclusions:
Associations of schizophrenia risk with degree of fetal growth restriction and pre-eclampsia suggest future research into schizophrenia etiology focusing on mechanisms that influence fetal growth, including placental function.
More Related Videos
05:44Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1
Published on: May 17, 2024
14:19Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
Published on: June 29, 2013
Related Concept Videos
Psychological and Sociocultural Causes of Schizophrenia
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Schizophrenia
Teratogenicity
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...